Navigation Links
IntraMed Diagnostics Announces Two Senior-Level Additions
Date:5/15/2013

Boulder, Colo. (PRWEB) May 15, 2013

IntraMed Diagnostics, LLC, a subsidiary of Express Diagnostics Int’l (EDI), is pleased to welcome Dean Kingston as director of engineering and manufacturing and Barry Vant-Hull, Ph.D., as senior software engineer.

Kingston to serve as director of engineering and manufacturing

Kingston previously served as engineering manager and senior product development engineer for Eveia Medical, Inc. While with Eveia Medical, he led the design, research, and development of the ArcFlow™ Point-of-Care platform, designed to be implemented in a variety of quantitative tests, including devices intended for testing coagulation rates (blood thinners), C-reactive protein (CRP), HbA1c, and several other potential clinical diagnostics applications.

Eveia’s patent pending cell quantitation technology will also be incorporated into EDI’s AnemiaCheck™ POC Quantitative Hematocrit Test, which will be available for export in Q3 2013. IntraMed Diagnostics recently acquired an option for future development of Eveia Medical’s complete portfolio of point-of-care clinical diagnostic testing assets.

Kingston began his career at B-Ten Systems, Inc., designing robotic assembly machines for medical industries. The company specializes in custom automation, robotics, and machine design manufacturing. As vice president of engineering, Kingston led many high-profile projects, implemented Pro/Engineer® design software with Pro/Intralink® data storage, and established a quality assurance system, design controls, and design standards. He later joined the executive team of Bolt Industries, Inc., where he served as general manager of the company’s Minnesota facility.

“Dean will be key to bringing our innovative testing devices to market. His design and manufacturing skills will help to ensure robust test performance in the field, while maintaining designs that can be manufactured on efficient, fully-automated lines,” says Steve Tyrrell, EDI and IntraMed vice president of research and development. “Having been a part of the team since the inception of the technologies, Dean’s experience will be important as we develop and introduce additional applications to market.”

Kingston is a graduate of Colorado State University, where he earned a degree in mechanical engineering with an emphasis in product design and manufacturing.

Vant-Hull directing integration of software with onsite testing platforms

Dr. Vant-Hull is the former director of research and development at Eveia Medical. During his tenure he was responsible for developing hardware and software to support a new in vitro diagnostics platform for clinical laboratories. Additionally, he has an extensive background in software development, including laboratory automation, high-throughput screening robotic workstations, and development of a tiered Java-based framework for integrating third-party and in-house devices for automating laboratory protocols.

“Dr. Vant-Hull brings the valuable combination of strong software development skills and a sound understanding of science and mathematics. These skills will enable us to develop innovative software applications that are easy to use, while applying advanced algorithms that enhance the performance of associated testing devices,” says Tyrrell. “We look forward to benefitting from Dr. Vant-Hull’s extensive background in biochemistry, engineering, and software development as we further develop our onsite diagnostic technologies.”

During his postdoctoral research at the University of Colorado, Dr. Vant-Hull assisted in biochemical engineering and molecular biology while studying high-density hybridoma cultures in bioreactors. He holds a doctorate in biochemical engineering and a masters of science from the University of Colorado.

Both Kingston and Vant-Hull are based out of the IntraMed Diagnostics facility in Boulder, Colo.

About IntraMed Diagnostics, LLC
IntraMed Diagnostics, LLC, a subsidiary of Express Diagnostics Int’l, Inc., was established to increase market penetration in the point-of-care testing market, a rapidly expanding multi-billion dollar industry. The company conducts engineering, research, and development for onsite in vitro diagnostic drugs of abuse screening and health diagnostics applications. Learn more at intrameddx.com.

About Express Diagnostics Int’l, Inc.
Express Diagnostics Int’l manufactures and distributes DrugCheck® on-site urine and saliva screening devices for the detection of drugs of abuse, as well as a growing catalog of health screening devices. With accuracy comparable to laboratory testing, Express Diagnostics onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services. Learn more at drugcheck.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10732936.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioConference Live Lands CMO of Roche Diagnostics and Other High Level Speakers
2. Exosome Diagnostics Names Kapil Dhingra Chairman of the Board of Directors
3. TrueVision® 3D Surgical and i-Optics Announce Collaboration to Integrate Diagnostics and Computer-Guidance in Cataract Surgery
4. Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing
5. Advanced Animal Diagnostics Raises $6 Million for On-farm Diagnostics
6. Slone Partners CEO & President Speak about Hiring Challenges in Molecular Diagnostics at Executive War College 2013
7. MGC Diagnostics Corporation Announces Special Cash Dividend and Extension of Stock Repurchase Program
8. Dominion Diagnostics to Sponsor 2013 Addiction Professional Panel Series as Thought Leadership Partner
9. PrimeraDx to Co-Develop Companion Diagnostics with Quest Diagnostics
10. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
11. DMG is Proud to Announce that CD Diagnostics will be Featured in an Upcoming Episode of Health Heroes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... and SAN FRANCISCO , ... privately-held regenerative medicine company, and Beyond Type 1, a ... type 1 diabetes, today announced a grant from Beyond ... functional cure for type 1 and other insulin-requiring diabetes.  ... has been developing innovative stem cell-derived cell replacement therapies ...
(Date:2/22/2017)... Feb. 22, 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a ... of innovative biopharmaceutical products for companion animals, will host a ... a.m. ET to discuss financial results from the fourth quarter ... Interested participants and investors may access the audio webcast ... ...
(Date:2/22/2017)... ... ... Park Systems , a leader in Atomic Force Microscopy (AFM) since ... attendees and Park customers on Feb. 27, 2017 from 12-2pm at Morton’s The Steakhouse ... The luncheon will feature a talk on Automated AFM for Small-Scale and Large-Scale Surface ...
(Date:2/22/2017)... Scientists propose in Nature blocking ... Gaucher and maybe other lysosomal storage diseases as a ... current therapies. An international research team led ... also included investigators from the University of Lübeck in ... 22. The study was conducted in mouse models of ...
Breaking Biology Technology:
(Date:2/8/2017)... 7, 2017 Report Highlights The ... from $8.3 billion in 2016 at a compound annual ... Report Includes - An overview of the global ... with data from 2015 and 2016, and projections of ... of the market on the basis of product type, ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute announced ... Larry Schlesinger as the Institute,s new President and ... effective May 31, 2017. He is currently the Chair of ... the Center for Microbial Interface Biology at Ohio State University. ... the new President and CEO of Texas Biomed," said Dr. ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, ... a new report, Sensors for Robotics: Technologies, Markets and Forecasts ... ... Revenues ... "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force ...
Breaking Biology News(10 mins):